Tryptanthrin inhibits interferon-γ production by Peyer's patch lymphocytes derived from mice that had been orally administered staphylococcal enterotoxin

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 3, 2003, Pages 365-367

  Takei, Yasuhiko ^a   Kunikata, Toshio ^a   Aga, Miho ^a   Inoue, Shin Ichiro ^a   Ushio, Shimpei ^a   Iwaki, Kanso ^a   Ikeda, Masao ^a   Kurimoto, Masashi ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

Cytokine; Superantigen; Tryptanthrin

Indexed keywords

INTERLEUKIN 2; PLANT EXTRACT; POLYGONUM TINCTORIUM EXTRACT; STAPHYLOCOCCUS ENTEROTOXIN B; TRYPTANTHARIN; UNCLASSIFIED DRUG; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; GAMMA INTERFERON; HERBACEOUS AGENT; QUINAZOLINE DERIVATIVE; TRYPTANTHRINE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; FEMALE; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MEDICINAL PLANT; MOUSE; NONHUMAN; PEYER PATCH; POLYGONUM TINCTORIUM; PROVOCATION TEST; SPLEEN CELL; STAPHYLOCOCCUS; STATISTICAL SIGNIFICANCE; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG INTERACTION; LYMPHOCYTE; METABOLISM; TIME;

ANIMALS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUGS, CHINESE HERBAL; ENTEROTOXINS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTES; MICE; MICE, INBRED BALB C; PEYER'S PATCHES; QUINAZOLINES; TIME FACTORS;

EID: 0642348909     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.365     Document Type: Article

References (24)

1. Honda G , Tabata M., Tsuda M., Planta Med , 37, 172-174 (1979).
2. Hashimoto T., Aga H., Chaen H., Fukuda S., Kurimoto M., Natural Medicines, 53, 27-31 (1999).
3. Kataoka M., Hirata K., Kunikata T., Ushio S., Iwaki K., Ohashi K., Ikeda M., Kurimoto M., J. Gastroenterol., 36, 5-9 (2001).
4. Kimoto T , Hino K., Koya-Miyata S., Yamamoto Y., Takeuchi M., Nishizaki Y , Micallef M. J., Ushio S , Iwaki K., Ikeda M., Kurimoto M., Pathol Int., 51, 315-325 (2001)
5. Koya-Miyata S., Kimoto T , Micallef M. J., Hino K., Taniguchi M., Ushio S., Iwaki K., Ikeda M., Kurimoto M., Anticancer Res., 21, 3295-3300 (2001)
6. Ishihara T., Kohno K., Ushio S , Iwaki K., Ikeda M., Kurimoto M., Eur. J. Pharmacol., 407, 197-204 (2000)
7. Danz H., Stoyanova S., Wippich P , Brattstrom A., Hamburger M., Planta Med., 67, 411-416 (2001).
8. Micallef M J., Iwaki K., Ishihara T., Ushio S., Aga M., Kunikata T., Koya-Miyata S., Kimoto T., Ikeda M., Kurimoto M., Int. Immunopharmacol , 2, 565-578 (2002).
9. Krakauer T., Immunol. Res , 20, 163-173 (1999).
10. Torres B. A , Kominsky S., Perrin G. Q., Hobeika A. C., Johnson H. M., Exp Biol Med., 226, 164-176 (2001).
11. Hamad A R. A., Marrack P., Kappler J. W., J. Exp Med., 185, 1447-1454 (1997).
12. Wilson A. D., Bailey M., Williams N. A., Stokes C. R., Eur. J. Immunol., 21, 2333-2339 (1991).
13. Kohno K., Kataoka J., Ohtsuki T., Suemoto Y , Okamoto I , Usui M., Ikeda M., Kurimoto M., J. Immunol , 158, 1541-1550, 1997.
14. Kohno K., Ohtsuki T., Suemoto Y., Inoue T , Taniguchi Y., Usui M., Ikeda M., Kurimoto M., Cellular Immunol., 168, 211-219, 1996.
15. Zhi-Jun Y , Sriranganathan N., Vaught T., Arastu S K., Ahmed S. A., J. Immunol. Methods, 210, 25-39, 1997.
16. Assenmacher M., Lohning M. Scheffold A., Manz R. A., Schmitz J , Radbruch A , Eur. J. Immunol., 28, 1534-1543, 1998.
17. Florquin S., Amraoui Z , Abramowicz D., Goldman M., J. Immunol., 153, 2618-2623 (1994).
18. Matthys P., Mitera T., Heremans H., Van Damme J , Billiau A., Infect. Immun., 63, 1158-1164 (1995).
19. Stiles B. G., Campbell Y G., Castle R. M., Grove S. A., Infect. Immun., 67, 1521-1525 (1999).
20. Celada A., Maki R. A., J Immunol., 146, 114-120 (1991).
21. McKay D. M., Singh P. K., J Immunol , 159, 2382-2390 (1997).
22. Spiekermann G. M., Nagler-Anderson C., J. Immunol., 161, 5825-5831 (1998).
23. Hawiger J , Immunol Res., 23, 99-109 (2001).
24. Barnes P. J., Karin M., N. Engl. J. Med , 336, 1066-1071 (1997).